HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,717,879 | -46.8% | 908,845 | -49.8% | 0.02% | -46.9% |
| Q2 2023 | $65,279,811 | +167679.9% | 1,809,809 | +77.6% | 0.03% | +45.5% |
| Q1 2023 | $38,908 | +1237.5% | 1,018,789 | +1892.8% | 0.02% | +1000.0% |
| Q4 2022 | $2,909 | -100.0% | 51,124 | -94.7% | 0.00% | -91.3% |
| Q3 2022 | $38,462,000 | +1205.1% | 972,738 | +1352.2% | 0.02% | +1050.0% |
| Q2 2022 | $2,947,000 | +16.9% | 66,984 | +5.9% | 0.00% | +100.0% |
| Q1 2022 | $2,522,000 | -60.8% | 63,238 | -60.5% | 0.00% | -66.7% |
| Q4 2021 | $6,438,000 | -40.3% | 160,098 | -39.6% | 0.00% | -50.0% |
| Q3 2021 | $10,791,000 | +10.2% | 265,273 | +23.0% | 0.01% | 0.0% |
| Q2 2021 | $9,791,000 | +637.8% | 215,623 | +577.5% | 0.01% | +500.0% |
| Q1 2021 | $1,327,000 | -90.2% | 31,826 | -90.0% | 0.00% | -90.0% |
| Q4 2020 | $13,547,000 | +1084.2% | 317,175 | +643.5% | 0.01% | +400.0% |
| Q2 2020 | $1,144,000 | -85.7% | 42,658 | -90.4% | 0.00% | -88.9% |
| Q1 2020 | $8,000,000 | -57.2% | 444,702 | -57.8% | 0.02% | -21.7% |
| Q4 2019 | $18,704,000 | +282.7% | 1,054,963 | +234.7% | 0.02% | +187.5% |
| Q3 2019 | $4,888,000 | +263.4% | 315,161 | +325.9% | 0.01% | +300.0% |
| Q3 2018 | $1,345,000 | -3.6% | 73,996 | -10.5% | 0.00% | 0.0% |
| Q2 2018 | $1,395,000 | -94.8% | 82,714 | -94.0% | 0.00% | -94.4% |
| Q1 2018 | $26,902,000 | -10.0% | 1,373,247 | -6.9% | 0.04% | -12.2% |
| Q4 2017 | $29,886,000 | +132.1% | 1,475,143 | +99.0% | 0.04% | +105.0% |
| Q3 2017 | $12,879,000 | +70.2% | 741,437 | +25.6% | 0.02% | +53.8% |
| Q2 2017 | $7,567,000 | +143.6% | 590,259 | +146.3% | 0.01% | +116.7% |
| Q1 2017 | $3,106,000 | -36.5% | 239,687 | -51.6% | 0.01% | -40.0% |
| Q4 2016 | $4,894,000 | +52.8% | 495,299 | +86.8% | 0.01% | +100.0% |
| Q3 2016 | $3,203,000 | +0.2% | 265,098 | -28.4% | 0.01% | -28.6% |
| Q2 2016 | $3,196,000 | +15.4% | 370,285 | +26.6% | 0.01% | 0.0% |
| Q1 2016 | $2,769,000 | +111.9% | 292,428 | +287.6% | 0.01% | +133.3% |
| Q4 2015 | $1,307,000 | -96.8% | 75,440 | -97.5% | 0.00% | -96.2% |
| Q3 2015 | $41,195,000 | -67.4% | 3,067,386 | -45.2% | 0.08% | -66.5% |
| Q2 2015 | $126,464,000 | +86.4% | 5,600,691 | +17.9% | 0.24% | +89.7% |
| Q1 2015 | $67,832,000 | +879.9% | 4,750,128 | +562.3% | 0.13% | +740.0% |
| Q4 2014 | $6,922,000 | +150.0% | 717,258 | +135.7% | 0.02% | +114.3% |
| Q3 2014 | $2,769,000 | +6.4% | 304,289 | +15.5% | 0.01% | 0.0% |
| Q2 2014 | $2,603,000 | +14.0% | 263,425 | +72.9% | 0.01% | 0.0% |
| Q4 2013 | $2,284,000 | +758.6% | 152,360 | +532.0% | 0.01% | +600.0% |
| Q3 2013 | $266,000 | -76.6% | 24,106 | -83.1% | 0.00% | -66.7% |
| Q2 2013 | $1,136,000 | – | 142,894 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |